Abstract
The burden imposed by the COVID-19 pandemic differentially interferes with the outcomes of clinical trials of aging and dementia. We examined the impact of the lockdown on cognitive impairment due to Alzheimer’s Disease (AD), anxiety, and COVID-19-related stress in participants from the Translational Biomarkers In Aging and Dementia (TRIAD) cohort using neuropsychiatric assessments, tau and amyloid PET. We found that, before the lockdown, anxiety was higher in cognitively impaired individuals (CI) and positively associated with brain tau load. However, during the lockdown, anxiety increased only in the cognitively unimpaired (CU) and was positively associated with COVID-19 related stress. Interestingly, we found that in patients, tau load was anti-correlated with higher anxiety during lockdown. Our findings contribute to a framework for interpreting the effects of the pandemic on neuropsychiatric symptoms among clinical trial participants. Collectively, our results suggest that caregivers are more vulnerable to external stressors than patients.
Introduction
The COVID-19 pandemic served as a unique, unplanned "natural experiment" in global stress. For researchers studying aging and dementia, this created a significant challenge: how to interpret clinical trial results when every participant is living through a period of intense isolation and fear. This study investigates whether existing brain pathology—specifically the accumulation of amyloid-beta and tau proteins—changes how an individual responds to external environmental stress. Specifically, the authors sought to determine if cognitively impaired (CI) individuals were more vulnerable to the psychological toll of the lockdown compared to cognitively unimpaired (CU) "healthy" controls.
Methods and Data
The researchers utilized data from the Translational Biomarkers In Aging and Dementia (TRIAD) cohort at McGill University. The study included 203 participants (133 CU; 70 CI).
Assessment and Imaging
Participants underwent multimodal imaging, including PET scans to measure brain levels of tau ([18F]MK-6240) and amyloid-beta ([18F]AZD-4694). Longitudinal tracking compared neuropsychiatric assessments (GAD-7 for anxiety, MMSE, and MoCA for cognition) taken before the pandemic to assessments conducted via telephone during the peak of the 2020 lockdown.
To quantify the shift in mental health and cognition over the lockdown period, the researchers calculated the rate of change for each metric using the following formula:
Key Insights
The "Insight Buffer"
A striking finding was that while anxiety increased in healthy seniors, it actually decreased or remained stable in those with cognitive impairment. The data suggests that because CI patients had lower "knowledge of COVID-19" and lower global cognition, they were less able to perceive the pandemic as a threat, effectively "buffering" them from external stress.
Tau’s Dual Role
Before the pandemic, higher tau load was associated with higher "endogenous" anxiety (anxiety caused by the disease itself). However, during the lockdown, high tau load was anti-correlated with anxiety changes. Essentially, the more advanced the disease, the less the patient reacted to the outside world’s chaos.
Caregiver Vulnerability
The results highlight a "hidden" victim of the pandemic. Since healthy older adults (who are often the primary caregivers for those with dementia) showed the highest increase in anxiety and the strongest link between COVID-stress and mental health, they were likely the most psychologically burdened group.
Key Results Summary
- Anxiety Trends: In the CU group, mean anxiety scores rose from 2.19 to 2.81. In the CI group, scores actually dropped from 3.62 to 2.47.
- Knowledge Gap: CU individuals scored significantly higher on COVID-19 knowledge than CI individuals ($p < 0.01$), supporting the theory that reduced situational awareness lowered stress.
- Imaging Correlation: In CI participants, a significant negative association was found between tau deposition in several brain regions (including the superior temporal and parietal gyri) and the change in anxiety. Amyloid-beta load showed no significant association with change in anxiety during the lockdown.
Limitations and Future Work
The study is limited by its observational nature and the necessary shift from in-person to telephone assessments during the lockdown. Future work should investigate the long-term neurological impact of this "blunted" stress response and whether it leads to different clinical outcomes. Additionally, more focus is needed on the mental health of caregivers, who appear to be the most vulnerable to external environmental stressors.
Summary updated